SCHEMBL5590091

SCHEMBL5590091

CCCCCCCOOc1c(O)c(C(=O)O)c(CC)c(CC)c1CC

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
PLA2G4B P0C869 1/20 0.35
ESR1 P03372 3/20 0.35
AKR1C4 P17516 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
BID P55957 3/20 0.34
MCL1 Q07820 3/20 0.34
RARB P10826 3/20 0.34
BCL2L1 Q07817 2/20 0.34
BAK1 Q16611 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589124 1.00 PLA2G2A (0.36) PLA2G2ATP53TSHRPLA2G4BESR1
SCHEMBL5587776 1.00 PLA2G2A (0.36) PLA2G2ATP53TSHRPLA2G4BESR1
SCHEMBL5588676 1.00 PLA2G2A (0.36) PLA2G2ATP53TSHRPLA2G4BESR1
SCHEMBL5588273 1.00 PLA2G2A (0.36) PLA2G2ATP53TSHRPLA2G4BESR1
SCHEMBL5590756 0.99 PLA2G2A (0.34) PLA2G2ATP53TSHRPLA2G4BESR1
SCHEMBL5586611 0.94 ESR1 (0.35) TP53TSHRPLA2G4BESR1BID
SCHEMBL5587464 0.91 PLA2G2A (0.40) PLA2G2ATP53TSHRPLA2G4BRARB
SCHEMBL5589759 0.91 PLA2G2A (0.40) PLA2G2ATP53TSHRPLA2G4BRARB
SCHEMBL5588540 0.91 PLA2G2A (0.40) PLA2G2ATP53TSHRPLA2G4BRARB
SCHEMBL5588026 0.88 LDHA (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PLA2G2A 4233/4885TP53 3753/4885TSHR 4680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.